Formulation of neomycin sulphate 0.35 % (W V) and hydrocortisone 0.5% otic drop
Joint Authors
Muhammad, Awatif Ibrahim
Jasim, Hanin Muhammad
Source
Iraqi Journal of Industrial Research
Issue
Vol. 9, Issue 1 (30 Jun. 2022), pp.115-119, 5 p.
Publisher
Ministry of Industry and Minerals Corporation of Research and Industrial Development
Publication Date
2022-06-30
Country of Publication
Iraq
No. of Pages
5
Main Subjects
Topics
Abstract EN
Neomycin sulfate and hydrocortisone ear drops of veterinary pharmaceuticals used as an antibiotic and ant inflammatory to treat infections caused by bacterial infections in the middle ear of large and small field animals caused by gram positive and negative bacteria like, Staphylococcus aureus, Escherichia coli, Homophiles influenza, Klebsiella–Enterobacter species, Neisseria species, and Pseudomonas aeruginosa.
The action of mechanism neomycin sulfate is inhibition of protein synthesis in bacteria cell which is lead to kill the bacteria and the action of hydrocortisone is ant inflammation in the infected area in animals.
In order for this preparation to be researched and applied, several primary pharmaceutical preparations were prepared until the final and stable structure was reached.
The amount of the active substance at room temperature was 100% .
This activity is good and within the permissible limits According to the veterinary constitutions [90-110].
This process involved several stages of collecting information in the materials involved in the formulation and from effective and added materials And then the preparation of the composition according to the international pharmaceutical specifications using the constitutions of the drug followed by the study of stability and resistance to the product temperature room and then send samples for field examination Department of Veterinary, was used in the treatment of cases of bacterial infections of the middle ear infections in cats use 3 or 4 drops in the affected ear three or four times for 3-5 days and results came very good according the clinical Neomycin sulfate and hydrocortisone ear drops of veterinary pharmaceuticals used as an antibiotic and ant inflammatory to treat infections caused by bacterial infections in the middle ear of large and small field animals caused by gram positive and negative bacteria like, Staphylococcus aureus, Escherichia coli, Homophiles influenza, Klebsiella–Enterobacter species, Neisseria species, and Pseudomonas aeruginosa.
The action of mechanism neomycin sulfate is inhibition of protein synthesis in bacteria cell which is lead to kill the bacteria and the action of hydrocortisone is ant inflammation in the infected area in animals.
In order for this preparation to be researched and applied, several primary pharmaceutical preparations were prepared until the final and stable structure was reached.
The amount of the active substance at room temperature was 100% .
This activity is good and within the permissible limits According to the veterinary constitutions [90-110].
This process involved several stages of collecting information in the materials involved in the formulation and from effective and added materials And then the preparation of the composition according to the international pharmaceutical specifications using the constitutions of the drug followed by the study of stability and resistance to the product temperature room and then send samples for field examination Department of Veterinary, was used in the treatment of cases of bacterial infections of the middle ear infections in cats use 3 or 4 drops in the affected ear three or four times for 3-5 days and results came very good according the clinical evaluation.
American Psychological Association (APA)
Muhammad, Muhammad Jasim& Muhammad, Awatif Ibrahim& Jasim, Hanin Muhammad. 2022. Formulation of neomycin sulphate 0.35 % (W V) and hydrocortisone 0.5% otic drop. Iraqi Journal of Industrial Research،Vol. 9, no. 1, pp.115-119.
https://search.emarefa.net/detail/BIM-1381190
Modern Language Association (MLA)
Muhammad, Muhammad Jasim…[et al.]. Formulation of neomycin sulphate 0.35 % (W V) and hydrocortisone 0.5% otic drop. Iraqi Journal of Industrial Research Vol. 9, no. 1 (2022), pp.115-119.
https://search.emarefa.net/detail/BIM-1381190
American Medical Association (AMA)
Muhammad, Muhammad Jasim& Muhammad, Awatif Ibrahim& Jasim, Hanin Muhammad. Formulation of neomycin sulphate 0.35 % (W V) and hydrocortisone 0.5% otic drop. Iraqi Journal of Industrial Research. 2022. Vol. 9, no. 1, pp.115-119.
https://search.emarefa.net/detail/BIM-1381190
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 118-119
Record ID
BIM-1381190